AbbVie/J&J Withdrawal Of Imbruvica Indications Clears Space For Competitors

 
• By Alaric DeArment
  
AbbVie and J&J said they would withdraw two of Imbruvica's lymphoma indications • Source: Shutterstock

More from Anticancer

More from Therapy Areas